AZN

AZN

USD

AstraZeneca PLC American Depositary Shares

$82.030+1.380 (1.711%)

Prix en Temps Réel

Healthcare
Drug Manufacturers - General
Royaume-Uni

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$80.650

Haut

$82.110

Bas

$80.480

Volume

5.34M

Fondamentaux de l'Entreprise

Capitalisation Boursière

255.3B

Industrie

Drug Manufacturers - General

Pays

United Kingdom

Statistiques de Trading

Volume Moyen

4.52M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $61.24Actuel $82.030Haut $86.57

Actualités Connexes

BusinessWire

DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer

The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU® (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed as a first-line

Voir plus
DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer
CNBC

ServiceNow CEO denies AI companies are threatening enterprise software: 'They don't do what we do'

ServiceNow CEO Bill McDermott pushed back against the idea that artificial intelligence technology will make enterprise software redundant.

Voir plus
ServiceNow CEO denies AI companies are threatening enterprise software: 'They don't do what we do'
CNBC

Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.

Voir plus
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.